Structure of Klebsiella pneumoniae adenosine monophosphate nucleosidase.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 13 05 2022
accepted: 09 09 2022
entrez: 20 10 2022
pubmed: 21 10 2022
medline: 25 10 2022
Statut: epublish

Résumé

Klebsiella pneumoniae is a bacterial pathogen that is increasingly responsible for hospital-acquired pneumonia and sepsis. Progressive development of antibiotic resistance has led to higher mortality rates and creates a need for novel treatments. Because of the essential role that nucleotides play in many bacterial processes, enzymes involved in purine and pyrimidine metabolism and transport are ideal targets for the development of novel antibiotics. Herein we describe the structure of K. pneumoniae adenosine monophosphate nucleosidase (KpAmn), a purine salvage enzyme unique to bacteria, as determined by cryoelectron microscopy. The data detail a well conserved fold with a hexameric overall structure and clear density for the putative active site residues. Comparison to the crystal structures of homologous prokaryotic proteins confirms the presence of many of the conserved structural features of this protein yet reveals differences in distal loops in the absence of crystal contacts. This first cryo-EM structure of an Amn enzyme provides a basis for future structure-guided drug development and extends the accuracy of structural characterization of this family of proteins beyond this clinically relevant organism.

Identifiants

pubmed: 36264993
doi: 10.1371/journal.pone.0275023
pii: PONE-D-22-14060
pmc: PMC9584410
doi:

Substances chimiques

N-Glycosyl Hydrolases EC 3.2.2.-
Anti-Bacterial Agents 0
Purines 0
Nucleotides 0
Adenosine Monophosphate 415SHH325A
Pyrimidines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0275023

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM124898
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201700059C
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Biochemistry. 1971 Aug 31;10(18):3411-7
pubmed: 5118623
Toxicol Sci. 2010 Jul;116(1):140-50
pubmed: 20338993
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Methods. 2021 May;18(5):463-471
pubmed: 33963356
Methods Enzymol. 1978;51:263-70
pubmed: 357895
J Mol Biol. 2005 Aug 12;351(2):431-42
pubmed: 16005885
Biochemistry. 2019 Jul 30;58(30):3280-3292
pubmed: 31283204
J Biol Chem. 1986 Apr 5;261(10):4451-9
pubmed: 3485632
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61
pubmed: 27307579
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701
Biochem Soc Trans. 2021 Nov 1;49(5):2345-2355
pubmed: 34581758
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Front Microbiol. 2016 Jun 13;7:895
pubmed: 27379038
Eur J Biochem. 1968 Dec;7(1):137-45
pubmed: 4884583
Front Cell Infect Microbiol. 2020 Mar 17;10:107
pubmed: 32257966
Nat Methods. 2015 Oct;12(10):943-6
pubmed: 26280328
Nat Rev Microbiol. 2006 Sep;4(9):710-6
pubmed: 16894338
Structure. 2004 Aug;12(8):1383-94
pubmed: 15296732
Methods Mol Biol. 2020;2112:29-42
pubmed: 32006276
Microb Cell Fact. 2022 Jan 4;21(1):2
pubmed: 34983520
Proc Natl Acad Sci U S A. 1979 Jun;76(6):2730-4
pubmed: 111240
Biotechnol Adv. 2019 Jan - Feb;37(1):177-192
pubmed: 30500353
Sci Rep. 2015 Sep 15;5:14214
pubmed: 26370141
J Biol Chem. 1980 Nov 25;255(22):10867-74
pubmed: 7000783
J Biol Chem. 1984 Jun 10;259(11):6972-8
pubmed: 6327703
Proteins. 2019 Dec;87(12):1298-1314
pubmed: 31589784
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Front Microbiol. 2019 Apr 01;10:539
pubmed: 30988669
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Biochim Biophys Acta. 1992 Apr 17;1120(3):239-47
pubmed: 1576149
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
IUCrJ. 2021 Dec 10;9(Pt 1):98-103
pubmed: 35059214
Cancer Res. 1977 Jul;37(7 Pt 1):2043-9
pubmed: 861933
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Protein Sci. 2016 Jun;25(6):1096-114
pubmed: 26990888

Auteurs

Brian C Richardson (BC)

The Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America.

Roger Shek (R)

Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington School of Medicine, Seattle, WA, United States of America.

Wesley C Van Voorhis (WC)

Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington School of Medicine, Seattle, WA, United States of America.

Jarrod B French (JB)

The Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH